CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 9 No. 6
 

HIV Counseling and Testing-United States, 1993

July 1, 1995

Counseling and testing are important components of state and local HIV prevention programs [1]. Analysis of national data sources indicates that HIV antibody tests are obtained from a variety of testing sites, including private physicians, hospitals, and outpatient clinics (66.7%), and publicly funded sites (33.1%) [2]. This report uses data from CDC's 1993 Behavioral Risk Factor Surveillance System (BRFSS) to examine variations in rates of use of private and public HIV counseling and testing sites by state.

In 1993, a total of 49 states and the District of Columbia participated in the BRFSS, a state-specific, population-based, random-digit-dialed telephone survey that collects information monthly from U.S. adults aged 18 years or older. Thirteen questions about HIV/AIDS-related knowledge and attitudes, and HIV antibody testing history during the preceding year were asked only of respondents aged 65 years or younger. In 1993, a total of 84,039 persons responded to these questions (state-specific range: 993 to 3,367) [3]. Data for each state were weighted by demographic characteristics and by selection probability; results are representative of persons aged 18 to 65 years in each state.

A median of 25.5% of persons (range: 14.4% [Iowa] to 37.5% [Alaska]) answered yes to the question: "Except for donating or giving blood, have you ever had your blood tested for the AIDS virus infection?" The number (weighted estimate) of adults who had ever been tested for HIV was highest in California (6.3 million).

A median of 9.6% of persons (range: 4.1% [Maine and South Dakota] to 16.9% [District of Columbia]) reported obtaining HIV antibody tests primarily for diagnostic reasons. For this study, diagnostic HIV antibody tests were defined as those administered primarily to learn infection status, rather than voluntary tests to qualify for insurance, military induction, immigration, marriage license application, or employment. Persons categorized as having obtained diagnostic HIV antibody tests were identified by one of three responses to the question "What was the main reason you had your last AIDS blood test?":

1. "To find out if infected"

2. "Because of referral by a doctor or health department or sex partner"

3. "For routine checkup." This response was included in "diagnostic" reasons to avoid excluding respondents who initiated a routine examination to determine whether they were infected with HIV.

In 43 states and the District of Columbia, at least 50% (median: 60.9%) of respondents had obtained their last diagnostic test from a private physician, health maintenance organization, or private outpatient clinic. A median of 16.2% of persons (range: 5.0% [North Dakota] to 37.6% [Mississippi]) had obtained their last diagnostic test at a publicly funded prevention site (including health departments; AIDS, sexually transmitted disease [STD], or tuberculosis clinics; and drug treatment programs).

The estimated number of persons who obtained a diagnostic test at a publicly funded site during the preceding year correlated with the number of tests reported to CDC's HIV Counseling and Testing System by publicly funded sites in each state [4].

A median of 60.7% of persons who had obtained their most recent diagnostic HIV antibody test at a publicly funded site (range: 30.8% [New Jersey] to 95.7% [Oklahoma]) received counseling with their test results. In comparison, a median of 28.2% of persons who had obtained their tests from a private site (range: 7.7% [Kentucky] to 77.3% [Oklahoma]) received counseling. In 90% of the reporting areas, the number of persons who received counseling with their HIV test results was at least 1.5 times greater for persons tested at publicly funded sites than those tested at private sites.

Editorial Note from the CDC: The findings from the 1993 BRFSS document a high degree of state-specific variability in self-reported HIV antibody tests in the United States. This variability may reflect state-specific differences in such factors as the prevalence of HIV infection, and HIV testing in high-risk groups, the presence and impact of HIV prevention programs, and age distribution. The BRFSS estimates of the number of persons last tested for voluntary or diagnostic reasons at a publicly funded clinic correlated highly with estimates from CDC's HIV Counseling and Testing System, and the median percentage of respondents ever tested for HIV (25%) is consistent with estimates based on CDC's National Health Interview Survey (22%).

Health-care visits to seek and obtain HIV tests are important opportunities to counsel persons about the risk for HIV infection and methods to reduce such risk.1 The data in this report indicate that, in most states, approximately threefold more persons reported having obtained their HIV test from a private provider than from a public site; however, persons who had obtained their test from a private provider were substantially less likely to have reported receiving counseling than those who obtained tests at a public site. This finding underscores the need for physicians and other health-care providers in private settings to offer HIV counseling at the time patients receive their HIV test results.

Limitations

The findings in this report are subject to at least two limitations.

First, the sample size of persons who reported having had an HIV antibody test in individual states did not enable stratification by other respondent characteristics. For example, state-specific sample sizes precluded analysis to determine whether specific high-risk populations that obtained HIV antibody testing also received counseling.

Second, because the BRFSS is a telephone-based system, some persons at high risk for HIV infection most likely were excluded from the survey.

The BRFSS is a unique source for information about HIV antibody testing behaviors of U.S. adults--particularly patterns of HIV testing outside of public clinics--and can be used both at the federal and state levels to improve HIV prevention and intervention programs. Questions about CT in the 1993 BRFSS were developed based on input from state health departments; subsequent BRFSS surveys may incorporate additional HIV-related behavioral questions.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





1. Hinman AR: Strategies to prevent HIV infection in the United States. Am J Publ Health 81:1557-1559, 1991.

2. CDC: HIV counseling and testing services from public and private providers-United States, 1990. MMWR 41:743,749-752, 1992.

3. CDC: 1993 BRFSS quality control report. Atlanta, US Department of Health and Human Services, Public Health Service, CDC, 1994.

4. CDC: HIV counseling and testing data system: National profile, 1993. Atlanta, US Department of Health and Human Services, Public Health Service, CDC, 1994.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy